![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Köhler, Viktoria Florentine 
ORCID: https://orcid.org/0000-0002-2665-1181; Adam, Pia ORCID: https://orcid.org/0000-0003-3862-4639; Fuss, Carmina Teresa; Jiang, Linmiao; Berg, Elke; Frank-Raue, Karin; Raue, Friedhelm; Hoster, Eva; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Schildhaus, Hans-Ulrich ORCID: https://orcid.org/0000-0002-9856-7050; Negele, Thomas; Siebolts, Udo; Lorenz, Kerstin; Allelein, Stephanie; Schott, Matthias; Spitzweg, Christine und Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161
(2022):
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors — A Retrospective Multi-Center Registry Analysis.
In: Cancers, Bd. 14, Nr. 14, 3405
[PDF, 413kB]
ORCID: https://orcid.org/0000-0002-2665-1181; Adam, Pia ORCID: https://orcid.org/0000-0003-3862-4639; Fuss, Carmina Teresa; Jiang, Linmiao; Berg, Elke; Frank-Raue, Karin; Raue, Friedhelm; Hoster, Eva; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Schildhaus, Hans-Ulrich ORCID: https://orcid.org/0000-0002-9856-7050; Negele, Thomas; Siebolts, Udo; Lorenz, Kerstin; Allelein, Stephanie; Schott, Matthias; Spitzweg, Christine und Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161
(2022):
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors — A Retrospective Multi-Center Registry Analysis.
In: Cancers, Bd. 14, Nr. 14, 3405
[PDF, 413kB]
Adam, Pia; Kircher, Stefan; Sbiera, Iuliu; Koehler, Viktoria Florentine; Berg, Elke; Knoesel, Thomas; Sandner, Benjamin; Fenske, Wiebke Kristin; Blaeker, Hendrik; Smaxwil, Constantin; Zielke, Andreas; Sipos, Bence; Allelein, Stephanie; Schott, Matthias; Dierks, Christine; Spitzweg, Christine; Fassnacht, Martin und Kroiss, Matthias
(12. August 2021):
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale.
In: Frontiers in Endocrinology, Bd. 12
[PDF, 2MB]
Koehler, Viktoria Florentine; Berg, Elke; Adam, Pia; Weber, Gian-Luca; Pfestroff, Andreas; Luster, Markus; Kutsch, Jana Maria; Lapa, Constantin; Sandner, Benjamin; Rayes, Nada; Fuss, Carmina Teresa; Kreissl, Michael; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Todica, Andrei; Fassnacht, Martin; Kroiss, Matthias und Spitzweg, Christine
(2021):
Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer.
In: Thyroid
Koehler, Viktoria Florentine; Berg, Elke; Adam, Pia; Weber, Gian-Luca; Pfestroff, Andreas; Luster, Markus; Kutsch, Jana Maria; Lapa, Constantin; Sandner, Benjamin; Rayes, Nada; Fuss, Carmina Teresa; Kreissl, Michael C.; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Todica, Andrei; Fassnacht, Martin; Kroiss, Matthias und Spitzweg, Christine
(2021):
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
In: Thyroid, Bd. 31, Nr. 10: S. 1531-1541
Koehler, Viktoria F.; Adam, Pia; Frank-Raue, Karin; Raue, Friedhelm; Berg, Elke; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Kroiss, Matthias und Spitzweg, Christine
(2020):
Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
In: Thyroid, Bd. 31, Nr. 3: S. 459-469